AINDEX
Markets

Pacific Biosciences of California, Inc. (PACB)

PACBNASDAQ-GSBiotechnology: Laboratory Analytical Instruments

$2.36

+0.1050 (+4.66%) today

Closed, Nov 9, 4:00 PM ET

+4.66% 1D
Market cap
$738.51m
P/E
–
EPS, last 4 quarters
$-0.4900
Dividend yield
–
Day range
–
52-week range
$1.07 to $3.44
Average volume
13.54m
Previous close
$2.26

Analysts

4 covering

Hold2 buy, 1 hold, 1 sell

Targets a year out average $2.64, +11.9% from here

$2.00now $2.36$3.00

Earnings

next estimate $-0.1300

Next report

Dec 2025

+36.8%

Mar 2026

+29.4%

Jun 2026

0.0%

Sep 2026

+15.4%

estimate reported, and the surprise

Financials

QuarterSep 2025Dec 2025Mar 2026Jun 2026
Revenue$38.44m$44.65m$37.18m$39.01m
Gross profit$15.90m$16.57m$12.84m$12.64m
Operating income-$38.88m-$41.20m-$8.36m-$44.61m
Net income-$38.00m-$40.37m-$8.28m-$44.74m

Last four quarters: revenue $159.27m, margin -82.5%, free cash flow -$123.42m

News

8 latest

The company

PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.

Sector
Industrials
Industry
Biotechnology: Laboratory Analytical Instruments
Exchange
NASDAQ-GS
Region
North America
Website
pacb.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

Pacific Biosciences of California, Inc. (PACB) price, chart and news · AINDEX